Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Breast Implant Related Cancer Legal News Articles & Interviews

Allergan Refuses to Pay for Surgery to Remove Breast Implants Linked to Cancer

Allergan Refuses to Pay for Surgery to Remove Breast Implants Linked to Cancer December 1, 2020. By Anne Wallace.
Hackensack, NJ  Jody Craft has now joined the growing number of women who have filed lawsuits seeking compensation for the harm Allegan USA, Inc. allegedly caused by marketing textured breast implants now linked to breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). BIA-ALCL is a rare form of cancer seen almost exclusively in women who have received textured breast implants.
Read [ Allergan Refuses to Pay for Surgery to Remove Breast Implants Linked to Cancer ]

Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL

Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL October 1, 2020. By Anne Wallace.
Washington, DC  A recently published study links breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) to implants manufactured by seven pharmaceutical companies. In addition to Allergan, the manufacturer of Biocell textured breast implants, the study names Mentor Worldwide, a unit of Johnson & Johnson, Silimed Polyurethane, Eurosilicone, Nagor, Orion, and Poly Implant Prothèse. Allergan faces at least 150 product liability and class action lawsuits. Mentor faces a smaller number, and none of the others are yet facing litigation.
Read [ Textured Breast Implants from Six More Manufacturers Linked to BIA-ALCL ]

FDA Update on BIA-ALCL Finds More Cases, More Deaths

FDA Update on BIA-ALCL Finds More Cases, More Deaths September 15, 2020. By Anne Wallace.
Silver Spring, MD  On August 20, the U.S. Food and Drug Administration provided an update on adverse events relating to breast implants, including breast implant-associated anaplastic large cell lymphoma. The new FDA update on BIA-ALCL reports a total of 733 cases and 36 patient deaths globally, an increase of 160 new cases and 3 deaths since July 2019. Of those 733 cases, 84.6 percent involved Allergan implants.
Read [ FDA Update on BIA-ALCL Finds More Cases, More Deaths ]

Deadly Secrets – Did Allergan Hide Breast Implant Side Effects?

Deadly Secrets – Did Allergan Hide Breast Implant Side Effects? August 3, 2020. By Anne Wallace.
New Orleans, LA A breast implant side effects lawsuit filed in the Eastern District of Louisiana may soon join the growing list of cases to be considered as part of the federal multidistrict litigation forming in New Jersey. Seuzeneau v. Allergan USA, Inc. charges that Allergan, which marketed, advertised and sold Biocell textured breast implants, failed to disclose the connection between the implants and BIA-ALCL, a rare form of cancer.
Read [ Deadly Secrets – Did Allergan Hide Breast Implant Side Effects? ]

New Jersey Allergan Biocell Textured Breast Implant Lawsuits Consolidated in New Jersey Superior Court

New Jersey Allergan Biocell Textured Breast Implant Lawsuits Consolidated in New Jersey Superior Court July 10, 2020. By Anne Wallace.
Hackensack, NJ On July 7, the initial case management conference for In Re: Allergan Biocell Textured Breast Implant Products Liability Litigation (the “MCL”) was held before Judge Rachelle Harz in New Jersey Superior Court in Bergen County. The consolidation of state law actions is intended to permit speedy, cost-effective and consistent management of the common issues that the breast implant side effects lawsuits are expected to share. This multicounty litigation will proceed in parallel with the multidistrict federal lawsuits (the “MDL”) that have been consolidated in Newark.
Read [ New Jersey Allergan Biocell Textured Breast Implant Lawsuits Consolidated in New Jersey Superior Court ]

FDA Indicates Possible Association With Rare Cancer and Breast Implants

January 26, 2011. By Lucy Campbell.
Washington, DC The Food and Drug Administration (FDA) announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma (ALCL), a very rare type of cancer. Data reviewed by the FDA suggest that patients with breast implants may have a very small but significant risk of ALCL in the scar capsule adjacent to the implant.
Read [ FDA Indicates Possible Association With Rare Cancer and Breast Implants ]


Request Legal Help Now! - Free